Posted On: 10/14/2015 7:24:04 PM
Post# of 72446
Ovidius, I share your frustration. No doubt that Leo screwed up the uplisting, but that’s not the sole reason for today’s share price. Unlike a failed clinical trial, the stock can recover to $2 in a short period of time.
Leo has done some positive things this year. He secured another favorable purchase agreement with Aspire. He got one, possibly two, orphan drug designation for K. P is ongoing with 9 sites. B-OM is ongoing with 6 sites. B-ABSSSI is making progress toward commencement.
You can’t take away a player’s salary just because he sucks. I think we should give Leo more time to move up the stock.
“It's not whether you got knocked down; it's whether you get back up.” - Vince Lombardi
Leo has done some positive things this year. He secured another favorable purchase agreement with Aspire. He got one, possibly two, orphan drug designation for K. P is ongoing with 9 sites. B-OM is ongoing with 6 sites. B-ABSSSI is making progress toward commencement.
You can’t take away a player’s salary just because he sucks. I think we should give Leo more time to move up the stock.
“It's not whether you got knocked down; it's whether you get back up.” - Vince Lombardi
(0)
(0)
